Symbols
Aime
Products
News
Market
Portfolio
Brokers
US Stocks
/
INKT
/
revenue
I
INKT
EPS
Revenue & Expenses
How did MiNK Therapeutics' expenses trend in Q4 2024?
Ask Aime more questions
